This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (98)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Diane K. Wysowski, PhD; Thomas P. Gross, MD, MPH

Arch Intern Med. 1990;150(10):2169-2172.

Abstract
• The Helsinki Heart Study and the Lipid Research Clinics Coronary Primary Prevention Trial both reported higher rates of deaths due to homicides, suicides, and accidents in the groups receiving cholesterol-lowering agents compared with the groups receiving placebos. We examined these deaths in the active treatment arms of the two trials to determine if there were some readily explainable causes or if the cholesterol-lowering agents might be a factor. Our examination showed that the two homicides were victims, not offenders, and one had stopped treatment because of myocardial infarction 1 year before his death. Five of the eight suicides had dropped out of the trials and had not taken the cholesterol-lowering drugs for periods of months to years prior to committing suicide. Of the 10 deaths due to accidents, two were dropouts from the trials, three others had high blood alcohol concentrations detectable at autopsy, and another three reported a history of psychiatric symptoms and/or treatment prior to entry. When dropouts and known risk factors for these deaths such as alcohol intoxication and psychiatric histories are considered, little evidence remains to support the hypothesis that cholesterol-lowering drugs are causally associated with deaths due to homicides, suicides, and accidents in these trials.

(Arch Intern Med. 1990;150:2169-2172)

Author Affiliations
From the Division of Epidemiology and Surveillance, Center for Drug Evaluation and Research, Food and Drug Administration, Rockville, Md.

Footnotes
Accepted for publication April 24, 1990.

This article contains the views of the authors and not necessarily those of the Food and Drug Administration.

Reprints not available.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy, part IV: The 1984 Coronary Primary Prevention Trial ends it--almost
Steinberg
J. Lipid Res. 2006;47:1-14.
ABSTRACT | FULL TEXT  

Serum cholesterol concentrations are associated with visuomotor speed in men: findings from the third National Health and Nutrition Examination Survey, 1988-1994
Zhang et al.
Am. J. Clin. Nutr. 2004;80:291-298.
ABSTRACT | FULL TEXT  

Severe irritability associated with statin cholesterol-lowering drugs
Golomb et al.
QJM 2004;97:229-235.
ABSTRACT | FULL TEXT  

Conceptual Foundations of the UCSD Statin Study: A Randomized Controlled Trial Assessing the Impact of Statins on Cognition, Behavior, and Biochemistry
Golomb et al.
Arch Intern Med 2004;164:153-162.
ABSTRACT | FULL TEXT  

Cause of death in clinical research: Time for a reassessment?
Lauer et al.
J Am Coll Cardiol 1999;34:618-620.
FULL TEXT  

Lipid-lowering therapy for the primary prevention of coronary heart disease
Gotto
J Am Coll Cardiol 1999;33:2078-2082.
FULL TEXT  

Depression as a risk factor for ischaemic heart disease in men: population based case-control study
Hippisley-Cox et al.
BMJ 1998;316:1714-1719.
ABSTRACT | FULL TEXT  

Low Cholesterol and Violence
Mufti et al.
Psychiatr. Serv. 1998;49:221-224.
ABSTRACT | FULL TEXT  

Lack of Relations of Hostility, Negative Affect, and High-Risk Behavior With Low Plasma Lipid Levels in the Coronary Artery Risk Development in Young Adults Study
Markovitz et al.
Arch Intern Med 1997;157:1953-1959.
ABSTRACT  

Lowered serum cholesterol and low mood
Brown
BMJ 1996;313:637-638.
FULL TEXT  

Commentary: Having too much evidence (depression, suicide, and low serum cholesterol)
Law
BMJ 1996;313:651-652.
FULL TEXT  

Serum cholesterol concentrations in parasuicide
Law and Wald
BMJ 1995;311:807a-807.
FULL TEXT  

Serum cholesterol concentraions in parasuicide
Gallerani et al.
BMJ 1995;310:1632-1639.
ABSTRACT | FULL TEXT  

Serum Cholesterol Level and Mortality Due to Suicide and Trauma in the Honolulu Heart Program
Iribarren et al.
Arch Intern Med 1995;155:695-700.
ABSTRACT  

Cholesterol and Violent Behavior
Santiago and Dalen
Arch Intern Med 1994;154:1317-1321.
ABSTRACT  

Improvements in Hostility and Depression in Relation to Dietary Change and Cholesterol Lowering: The Family Heart Study
Weidner et al.
ANN INTERN MED 1992;117:820-823.
ABSTRACT  

The Lipid Research Clinics Coronary Primary Prevention Trial: Results of 6 Years of Post-Trial Follow-up
The Lipid Research Clinics Investigators
Arch Intern Med 1992;152:1399-1410.
ABSTRACT  

Serum Cholesterol Level and Mortality Findings for Men Screened in the Multiple Risk Factor Intervention Trial
Neaton et al.
Arch Intern Med 1992;152:1490-1500.
ABSTRACT  

Lowering Cholesterol and Death due to Accidents, Suicides: Unresolved Issues
Vasan
Arch Intern Med 1992;152:414-414.
ABSTRACT  

Lowering Cholesterol and Death due to Accidents, Suicides: Unresolved Issues-Reply
Wysowski and Gross
Arch Intern Med 1992;152:414-417.
ABSTRACT  

Cholesterol, Primary and Secondary Prevention, and All-Cause Mortality
Criqui
ANN INTERN MED 1991;115:973-976.
ABSTRACT  

Does Cholesterol Lowering Increase Non--Illness-Related Mortality?
Muldoon et al.
Arch Intern Med 1991;151:1453-1453.
ABSTRACT  

Does Cholesterol Lowering Increase Non--Illness-Related Mortality?-Reply
Wysowski and Gross
Arch Intern Med 1991;151:1453-1454.
ABSTRACT  

Detection and Treatment of Elevated Blood Cholesterol: What Have We Learned?
Dalen
Arch Intern Med 1991;151:25-28.
ABSTRACT